We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Immunic Inc
7 own
7 watching
Current Price
$1.01
$0.01
(1%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
62.05M
52-Week High
2.11000
52-Week Low
0.97000003
Average Volume
3.57M
Dividend Yield
--
P/E Ratio
--
Market Capitalization62.05M52-Week High2.1100052-Week Low0.97000003Average Volume3.57MDividend Yield--P/E Ratio--What does the Immunic Inc do?
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Read More
How much money does Immunic Inc make?
News & Events about Immunic Inc.
Ticker Report
1 year ago
Immunic, Inc. (NASDAQ:IMUX Get Rating) Investment analysts at Wedbush issued their FY2027 earnings estimates for Immunic in a research note issued to investors on Tuesday, January 31st. Wedbush analyst L. Moussatos expects that the company will post earnings per share of ($1.62) for ...
PR Newswire
2years ago
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Ticker Report
2years ago
SVB Leerink cut shares of Immunic (NASDAQ:IMUX Get Rating) from an outperform rating to a market perform rating in a research report report published on Friday, MarketBeat reports. SVB Leerink currently has $5.00 price target on the stock. A number of other analysts have also commented on ...
PR Newswire
2years ago
Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? PR Newswire NEW YORK, Oct. 24, 2022 NEW YORK, Oct. 24, 2022...
PR Newswire
2years ago
Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Immunic Inc share price today?
Can Indians buy Immunic Inc shares?
How can I buy Immunic Inc shares from India?
Can Fractional shares of Immunic Inc be purchased?
What are the documents required to start investing in Immunic Inc stocks?
What is today’s traded volume of Immunic Inc?
What is today’s market capitalisation of Immunic Inc?
What is the 52-Week High and Low Range of Immunic Inc?
What percentage is Immunic Inc down from its 52-Week High?
What percentage is Immunic Inc up from its 52-Week Low?
Current Price
$1.01
$0.01
(1%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.